Calquence 100 mg film-coated tablets, Calquence 100 mg film-coated tablets
D8223C00016
Approved small_molecule active
Quick answer
Calquence 100 mg film-coated tablets, Calquence 100 mg film-coated tablets for Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment is a Approved program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment
- Phase
- Approved
- Modality
- small_molecule
- Status
- active